GENTILIN, Erica
 Distribuzione geografica
Continente #
NA - Nord America 4.280
AS - Asia 1.892
EU - Europa 1.268
SA - Sud America 332
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 7.817
Nazione #
US - Stati Uniti d'America 4.219
SG - Singapore 756
CN - Cina 599
BR - Brasile 273
DE - Germania 263
UA - Ucraina 222
HK - Hong Kong 175
IT - Italia 167
PL - Polonia 144
GB - Regno Unito 138
TR - Turchia 132
VN - Vietnam 121
FI - Finlandia 120
SE - Svezia 72
RU - Federazione Russa 55
CA - Canada 29
AR - Argentina 28
FR - Francia 28
MX - Messico 27
ID - Indonesia 22
ZA - Sudafrica 21
IN - India 18
BD - Bangladesh 17
JP - Giappone 15
BE - Belgio 13
AT - Austria 9
ES - Italia 9
IQ - Iraq 9
EC - Ecuador 8
KE - Kenya 7
PK - Pakistan 7
LT - Lituania 6
NL - Olanda 6
CL - Cile 5
CO - Colombia 5
EG - Egitto 5
UZ - Uzbekistan 5
VE - Venezuela 5
AL - Albania 3
CH - Svizzera 3
DZ - Algeria 3
EU - Europa 3
JO - Giordania 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
BG - Bulgaria 2
DO - Repubblica Dominicana 2
IL - Israele 2
MA - Marocco 2
MK - Macedonia 2
NP - Nepal 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
GA - Gabon 1
IE - Irlanda 1
IR - Iran 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
SA - Arabia Saudita 1
TN - Tunisia 1
UY - Uruguay 1
Totale 7.817
Città #
Ashburn 464
Singapore 458
Woodbridge 417
Fairfield 380
Chandler 323
Houston 305
Jacksonville 259
Beijing 212
Ann Arbor 206
Santa Clara 205
Hong Kong 174
Seattle 156
Warsaw 144
Wilmington 142
Cambridge 120
Addison 83
Los Angeles 74
Izmir 68
Munich 64
Nanjing 60
Ferrara 56
Princeton 55
Boardman 48
Ho Chi Minh City 41
New York 40
Helsinki 39
Milan 37
Shanghai 35
Dallas 33
Turku 30
San Diego 29
São Paulo 26
Hanoi 25
Dearborn 24
Nanchang 24
Buffalo 23
Bremen 21
Washington 21
Tianjin 20
Mexico City 19
Shenyang 19
Atlanta 17
Brooklyn 17
Changsha 17
Hebei 17
London 17
Mountain View 15
Nuremberg 15
Tokyo 15
Chicago 14
Denver 14
Frankfurt am Main 14
Jinan 14
Johannesburg 14
Jiaxing 13
Brussels 12
Jakarta 12
Chennai 11
Montreal 11
Padova 11
Guangzhou 10
Moscow 10
Auburn Hills 9
Orange 9
Stockholm 9
Falls Church 8
Manchester 8
Norwalk 8
Orem 8
Poplar 8
Tappahannock 8
The Dalles 8
Belo Horizonte 7
Indiana 7
Kunming 7
Nairobi 7
Toronto 7
Baghdad 6
Brasília 6
Columbus 6
Hefei 6
Hải Dương 6
Redwood City 6
Rio de Janeiro 6
Bologna 5
Campinas 5
Da Nang 5
Dong Ket 5
Haiphong 5
Ninh Bình 5
Phoenix 5
Porto Alegre 5
Augusta 4
Boston 4
Cagliari 4
Charlotte 4
Council Bluffs 4
Curitiba 4
Dhaka 4
Falkenstein 4
Totale 5.501
Nome #
Studio dell’azione del Mitotane, farmaco adrenolitico, sulla funzionalità ipofisaria 251
Igf-I influences everolimus activity in medullary thyroid carcinoma 224
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 215
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 211
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 211
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 200
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 190
Functional characterization of a new deletion in CDKN1B 5'-UTR region 186
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 185
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 183
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 182
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 181
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 177
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 172
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 171
Growth hormone induces chemoresistance in breast cancer cells 169
Cushing in a Leaf: Endocrine Disruption From a Natural Remedy 169
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 166
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 166
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 165
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 164
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 163
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 159
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells 157
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 153
Proto-oncogene PBF/PTTG1IP Regulates Thyroid Cell Growth and Represses Radioiodide Treatment 152
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 150
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 150
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 148
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 144
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 141
ctivation of EGFR promotes ACC cell proliferation by inducing VEGF autocrine secretion 137
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 134
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 128
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 125
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 123
mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures 119
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 117
PI3K/Akt/mTOR pathway involvement in regulating growth hormone secretion in a rat pituitary adenoma cell line 113
Targeting PKC in human pancreatic neuroendocrine tumor cells 108
IGF-I proliferative effects are inhibited by targeting PKC in human neuroendocrine tumor cells 106
miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta 102
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 101
CDK-Inhibitors as New Therapeutic Treatment for Human Bronchial Carcinoids 100
Validation of a murine model to study deregulated pituitary microRNA 95
miR-26a targets PRKCD in ACTH pituitary adenoma 95
null 92
MicroRNAs in the pituitary 91
Therapeutic concentrations of mitotane inhibit thyrotroph cell viability and TSH secretion in a mouse cell line model 86
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  82
null 81
miR-26a and cell cycle control in ACTH secreting pituitary adenoma 67
Protein kinase C delta mediates Pasireotide effects in an ACTH-secreting pituitary tumor cell line 65
Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors 61
Inhibitory effects of mitotane on viability and secretory activity in mouse gonadotroph cell lines 55
null 40
Totale 7.878
Categoria #
all - tutte 35.368
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.368


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021411 0 0 0 0 0 74 19 84 14 82 94 44
2021/2022504 26 37 31 7 22 31 22 17 15 50 53 193
2022/2023678 61 52 28 99 112 90 36 53 92 4 23 28
2023/2024357 32 36 25 11 39 56 15 69 4 3 3 64
2024/20251.241 30 25 91 22 175 174 35 36 159 136 188 170
2025/20261.873 303 149 277 423 620 101 0 0 0 0 0 0
Totale 7.878